Denosumab Increases Bone Density, Cuts Fracture Risk In Prostate Cancer Survivors
Monday, September 7, 2009 - 18:21
in Health & Medicine
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer, a study has found.